Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Cancer chemotherapy and pharmacology

Results: 1-25/207

Authors: BOWDEN CJ FIGG WD DAWSON NA SARTOR O BITTON RJ WEINBERGER MS HEADLEE D REED E MYERS CE COOPER MR
Citation: Cj. Bowden et al., A PHASE I II STUDY OF CONTINUOUS-INFUSION SURAMIN IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE-CANCER - TOXICITY AND RESPONSE/, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 1-8

Authors: ROWINSKY EK LUCAS VS HSIEH ALY WARGIN WA HOHNEKER JA LUBEJKO B SARTORIUS SE DONEHOWER RC
Citation: Ek. Rowinsky et al., THE EFFECTS OF FOOD AND DIVIDED DOSING ON THE BIOAVAILABILITY OF ORALVINORELBINE, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 9-16

Authors: HAN I KHOKHAR AR PEREZSOLER R
Citation: I. Han et al., INTRALIPOSOMAL CONVERSION OF LIPOPHILIC LATO-TRANS-R,R-1,2-DIAMINOCYCLOHEXANE-PLATINUM(II) COMPLEXES INTO LORO-TRANS-R,R-1,2-DIAMINOCYCLOHEXANE-PLATINUM(II), Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 17-24

Authors: JOHNSSON A HOGLUND P GRUBB A CAVALLINSTAHL E
Citation: A. Johnsson et al., CISPLATIN PHARMACOKINETICS AND PHARMACODYNAMICS IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE HEAD NECK OR ESOPHAGUS/, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 25-33

Authors: KHAN AA VILLABLANCA JG REYNOLDS CP AVRAMIS VI
Citation: Aa. Khan et al., PHARMACOKINETIC STUDIES OF 13-CIS-RETINOIC ADD IN PEDIATRIC-PATIENTS WITH NEUROBLASTOMA FOLLOWING BONE-MARROW TRANSPLANTATION, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 34-41

Authors: PERICLOU AP AVRAMIS VI
Citation: Ap. Periclou et Vi. Avramis, NONMEM POPULATION PHARMACOKINETIC STUDIES OF CYTOSINE-ARABINOSIDE AFTER HIGH-DOSE AND AFTER LOADING BOLUS FOLLOWED BY CONTINUOUS-INFUSION OF THE DRUG IN PEDIATRIC - PATIENTS WITH LEUKEMIAS, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 42-50

Authors: EGORIN MJ SENTZ DL ROSEN DM BALLESTEROS MF KEARNS CM CALLERY PS EISEMAN JL
Citation: Mj. Egorin et al., PLASMA PHARMACOKINETICS, BIOAVAILABILITY, AND TISSUE DISTRIBUTION IN CD2F1 MICE OF HALOMON, AN ANTITUMOR HALOGENATED MONOTERPENE ISOLATED FROM THE RED ALGAE PORTIERIA-HORNEMANNII, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 51-60

Authors: MINAMI H RATAIN MJ ANDO Y SHIMOKATA K
Citation: H. Minami et al., PHARMACODYNAMIC MODELING OF PROLONGED ADMINISTRATION OF ETOPOSIDE, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 61-66

Authors: KUBOTA Y NAKADA T YANAI H KAKIZAKI H SASAGAWA I WATANABE M
Citation: Y. Kubota et al., ELECTROPERMEABILIZATION IN BLADDER-CANCER CHEMOTHERAPY, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 67-70

Authors: BRUSERUD O
Citation: O. Bruserud, IN-VITRO EFFECTS OF R-VERAPAMIL ON THE CYTOKINE ENVIRONMENT AND T-LYMPHOCYTE PROLIFERATION WHEN HUMAN T-LYMPHOCYTE ACTIVATION TAKES PLACE IN THE PRESENCE OF ACUTE MYELOGENOUS LEUKEMIA BLASTS, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 71-78

Authors: VANLAAR JAM RUSTUM YM VANDERWILT C SMID K KUIPER CM PINEDO HM PETERS GJ
Citation: Jam. Vanlaar et al., TUMOR SIZE AND ORIGIN DETERMINE THE ANTITUMOR-ACTIVITY OF CISPLATIN OR 5-FLUOROURACIL AND ITS MODULATION BY LEUCOVORIN IN MURINE COLON CARCINOMAS, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 79-89

Authors: OLIVI A EWEND MG UTSUKI T TYLER B DOMB AJ BRAT DJ BREM H
Citation: A. Olivi et al., INTERSTITIAL DELIVERY OF CARBOPLATIN VIA BIODEGRADABLE POLYMERS IS EFFECTIVE AGAINST EXPERIMENTAL GLIOMA IN THE RAT, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 90-96

Authors: COLL JM HICKEY RJ WEI YT MALKAS LH
Citation: Jm. Coll et al., THE HUMAN CELL MULTIPROTEIN DNA-REPLICATION COMPLEX (MRC) - THE EFFECT OF CAMPTOTHECIN ON ITS ABILITY TO SUPPORT IN-VITRO DNA-SYNTHESIS, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 97-102

Authors: ZOU YY PRIEBE W PEREZSOLER R
Citation: Yy. Zou et al., LYOPHILIZED PRELIPOSOMAL FORMULATION OF THE NON-CROSS-RESISTANT ANTHRACYCLINE ANNAMYCIN - EFFECT OF SURFACTANT ON LIPOSOME FORMATION, STABILITY AND SIZE, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 103-108

Authors: BONNER JA KOZELSKY TF
Citation: Ja. Bonner et Tf. Kozelsky, THE SIGNIFICANCE OF THE SEQUENCE OF ADMINISTRATION OF TOPOTECAN AND ETOPOSIDE, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 109-112

Authors: ELIZONDO FG SUNG C
Citation: Fg. Elizondo et C. Sung, EFFECT OF ANGIOTENSIN-II ON IMMUNOTOXIN UPTAKE IN TUMOR AND NORMAL TISSUE, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 113-121

Authors: AHMED AE JACOB S GIOVANELLA BC KOZIELSKI AJ STEHLIN JS LIEHR JG
Citation: Ae. Ahmed et al., INFLUENCE OF ROUTE OF ADMINISTRATION ON [H-3] CAMPTOTHECIN DISTRIBUTION AND TUMOR UPTAKE IN CASE BEARING NUDE-MICE - WHOLE-BODY AUTORADIOGRAGHIC STUDIES, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 122-130

Authors: NAGAI N KINOSHITA M OGATA H TSUJINO O WADA Y SOMEYA K OHNO T MASUHARA K TANAKA Y KATO K NAGAI H YOKOYAMA A KURITA Y
Citation: N. Nagai et al., RELATIONSHIP BETWEEN PHARMACOKINETICS OF UNCHANGED CISPLATIN AND NEPHROTOXICITY AFTER INTRAVENOUS INFUSIONS OF CISPLATIN TO CANCER-PATIENTS, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 131-137

Authors: ZHU G OTO E VAAGE J QUINN Y NEWMAN M ENGBERS C USTER P
Citation: G. Zhu et al., THE EFFECT OF VINCRISTINE-POLYANION COMPLEXES IN STEALTH LIPOSOMES ONPHARMACOKINETICS, TOXICITY AND ANTI TUMOR-ACTIVITY, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 138-142

Authors: VOLPE DA TOMASZEWSKI JE PARCHMENT RE GARG A FLORA KP MURPHY MJ GRIESHABER CK
Citation: Da. Volpe et al., MYELOTOXIC EFFECTS OF THE BIFUNCTIONAL ALKYLATING AGENT BIZELESIN ON HUMAN, CANINE AND MURINE MYELOID PROGENITOR CELLS, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 143-149

Authors: FAZENY B ZIFKO U MERYN S HUBER H GRISOLD W DITTRICH C
Citation: B. Fazeny et al., VINORELBINE INDUCED NEUROTOXICITY IN PATIENTS WITH ADVANCED BREAST-CANCER PRETREATED WITH PACLITAXEL - A PHASE-II STUDY, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 150-156

Authors: TOLOMEO M GANCITANO RA MUSSO M PORRETTO F PERRICONE R ABBADESSA V CAJOZZO A
Citation: M. Tolomeo et al., COMPARATIVE ACTIVITY OF IDARUBICIN AND IDARUBICINOL IN COMBINATION WITH CYCLOSPORINE-A IN MULTIDRUG-RESISTANT LEUKEMIA-CELLS, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 157-161

Authors: KORST AEC GALL HE VERMORKEN JB VANDERVIJGH WJF
Citation: Aec. Korst et al., PHARMACOKINETICS OF AMIFOSTINE AND ITS METABOLITES IN THE PLASMA AND ASCITES OF A CANCER-PATIENT, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 162-166

Authors: STOCKERT JC JUARRANZ A VILLANUEVA A CANETE M
Citation: Jc. Stockert et al., PHOTODYNAMIC DAMAGE TO HELA-CELL MICROTUBULES INDUCED BY THIAZINE DYES, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 167-169

Authors: BATES PI SHARMA HL MURRER BA MCAULIFFE CA
Citation: Pi. Bates et al., THE TISSUE DISTRIBUTION IN BALB C MICE OF C-14-LABELED JM216, AN ORALLY-ACTIVE PLATINUM ANTITUMOR COMPOUND/, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 170-175
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>